Current Board of Directors
Dr James Abbey
Dr Abbey is Vice President of Strategic Business Development at iBio Inc. Formerly the Director for Global & Corporate Partnerships for The Texas A&M University System. He previously held the position of the International Strategic Collaborations Adviser and Director of the Texas/Unite Kingdom (UK) Collaborative & International Collaboration at Swansea University in Wales, United Kingdom. Dr. Abbey also holds research affiliations with Houston Methodist Hospital Research Institute as Assistant Affiliate Member, Visiting Scientist at Rice University in the Department of Chemistry, and Adjunct Professor in the College of Veterinary Medicine at Texas A&M University.
Mr Kenneth Donnelly 
Mr Donnelly is a Director of Risk at Bank of America, New York. His career extends over 25 years in commerce at major US financial institutions and major airlines. He first studied at the University of Glasgow in Mathematics and Computer Science followed by the Wharton School of Business, UPENN Pennsylvania. He was born in Bellshill, Scotland and is currently President of the Royal Scottish Country Dance Society – NY Branch, Vice President of the Robert Burns Society of New York City and member of the St. Andrews Society of New York.
Dr Malcolm Duncan
Dr Duncan is currently Director of Intellectual Property, SRI International based in Menlo Park, California. His background includes a career as a professor and researcher in particle physics, litigation practice on Wall Street, and intellectual property practice with New York and Chicago law firms. He holds a bachelor’s degree in Mathematical Physics from the University of Edinburgh, a doctorate in Theoretical Physics from the University of Oxford, and a Law degree from the University of Minnesota Law School.
Professor Edward Kleinert 
Prof Kleinert has worked as a senior program and project manager at Memorial Sloan-Kettering Cancer Center, specializing in enterprise wide human resources project initiatives. He is based in New York and his academic qualifications include an MBA from Stern Graduate School of Business Administration, New York University and an MPH from the School of Public Health and Graduate School of Business, Health Care Management and Administration, Columbia University. He has also worked for 20 years as Clinical Assistant Professor at the School of Professional Studies, Division of Programs in Business, New York University.
Dr Linda Lees
Dr Lees is director and founder of Creative Cities International (CCI), a New York and London based cities consultancy. CCI's groundbreaking research on cities is published in the Vitality Index™ (VI). She is based in New York. Her broad educational and cultural experience includes positions at New York University, The British Council, Georgetown University and the Smithsonian Institution. She was founder and artistic director of a theatre in Washington, DC. Her academic qualifications include a Ph.D. in Dramatic Art and an MA in Comparative Literature from the University of California at Berkeley.
Ian Wright
Ian is Chief Strategy Officer at Precision Medicine Initiative Cedars Sinai Medical Center Los Angeles. With a career that spans over 30 years in life-science commercialization and technology development, Ian has been a valued adviser to GenPro since its founding in 2014. Ian also serves as Board Member and Trustee for the Saint Andrew’s Society of Los Angeles.
Professor James F. Winchester 
Prof Winchester M.D., F.R.C.P. (Glas), F.A.C.P. (President) is a member of and former Chief of the Division of Nephrology and Hypertension and Vice Chairman, Department of Medicine at Beth Israel Medical Centre, New York. His long career began when he studied at the University of Glasgow, School of Medicine before going on to hold positions at Georgetown University Medical Centre, Washington DC, Downstate Medical Centre, Albert Einstein College of Medicine and Columbia University, New York. He is currently Professor of Medicine at Icahn School of Medicine at Mount Sinai, New York.